David Robert Boulware MD MPH
HIV/AIDS Medicine, International Health, Travel & Tropical
Distinguished Associate Professor of Medicine, University of Minnesota Medical School, Minneapolis
Join to View Full Profile
420 Delaware St SeMmc 250Minneapolis, MN 55455
Phone+1 612-625-7634
Dr. Boulware is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Boulware is an infectious disease specialist in Minneapolis, MN and is affiliated with University of Minnesota Medical Center, Fairview. He received his medical degree from Indiana University School of Medicine and has been in practice 17 years. He specializes in hiv/aids medicine and international health, travel & tropical and is experienced in cryptococcal meningitis, parasitic infections, vaccines, aids-related opportunistic infections, and diagnostic services.
Education & Training
University of MinnesotaFellowship, Infectious Disease, 2004 - 2007- University of MinnesotaResidency, Internal Medicine/Pediatrics, 2000 - 2004
Indiana University School of MedicineClass of 2000
Certifications & Licensure
MN State Medical License 2002 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Prevention of Jellyfish Stings
- Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine Start of enrollment: 2006 Mar 01
- Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-week and 1-year survival among Persons with HIV-Associated Cryptococcal Meningitis.Morris K Rutakingirwa, Kenneth Ssebambulidde, Samuel Okurut, Richard Kwizera, Martin Nabwana
The Journal of Infectious Diseases. 2025-08-21 - Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.Morris K Rutakingirwa, Caleb P Skipper, Biyue Dai, Abduljewad Wele, Suzan Namombwe
Clinical Infectious Diseases. 2025-08-07 - Cerebral Perfusion Pressures and Implications on Clinical Outcomes and Medical Management in Cryptococcal Meningitis.Mahsa Abassi, Cody Hou, Ann Fieberg, Biyue Dai, Abdu K Musubire
Open Forum Infectious Diseases. 2025-08-01
Journal Articles
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David Boulware, MD, The New England Journal of Medicine
- HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 CountsDavid Boulware, MD, The Journal of Infectious Diseases
- Oxford University Press Has Registered This DOI Pre-PublicationChristopher C Moore, David R Boulware, Eric R Houpt, Oxford University Press
- Join now to see all
Authored Content
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19June 2020
Press Mentions
With COVID Cases Rising This Summer, What to Know About the Paxlovid TreatmentJuly 23rd, 2025- Presentation for CDC Advisers Appears to Cite Nonexistent Study to Support Claims About Risk of Vaccine PreservativeJune 25th, 2025
- CDC Pulls Vaccine Slide After Expert Cites Study Doesn't ExistJune 24th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
